Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alessandro Padovani is active.

Publication


Featured researches published by Alessandro Padovani.


Journal of Neurology and Neuromedicine | 2016

COMMENTARY: Dementia after Three Months and One Year from Stroke: New Onset or Previous Cognitive Impairment?

Salvatore Caratozzolo; Andrea Scalvini; Francesco Lanfranchi; Silvia Pelizzari; Marina Zanetti; Luca Rozzini; Alessandro Padovani; footer; blockquote

In a non-negligible percentage of cases, ranging from 20% to 80%, stroke was associated with the occurrence of a variable degree of cognitive impairment5-8, from mild cognitive deficit to frank dementia. This wide range of prevalence rates could be attributed to differences in care setting, inclusion/exclusion criteria (presence of pre-stroke dementia, primary vs recurrent stroke), criteria adopted for the diagnosis of cognitive impairment, and the interval time after stroke.


Molecular Medicine | 2002

[alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients.

Francesca Colciaghi; B. Borroni; Lucia Pastorino; Elena Marcello; Martina Zimmermann; Flaminio Cattabeni; Alessandro Padovani; Monica Di Luca


JAMA Neurology | 2001

Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment.

B. Borroni; Francesca Colciaghi; Lucia Pastorino; Carla Pettenati; Elisabetta Cottini; Luca Rozzini; Roberto Monastero; Gian Luigi Lenzi; Flaminio Cattabeni; Monica Di Luca; Alessandro Padovani


Advances in Alzheimer's Disease | 2013

Early onset versus late onset in Alzheimer’s disease: What is the reliable cut-off?

Gianfranco Spalletta; Vincenzo De Luca; Alessandro Padovani; Luca Rozzini; Roberta Perri; Amalia C. Bruni; Vincenzo Canonico; Alberto Trequattrini; Giuseppe Bellelli; Carla Pettenati; Floriana Pazzelli; Carlo Caltagirone; Maria Donata Orfei


Molecular Medicine | 2000

Presenilin 2 mutation does not influence expression and concentration of APP forms in human platelets.

Lucia Pastorino; Francesca Colciaghi; G. Marcon; B. Borroni; Elisabetta Cottini; Flaminio Cattabeni; Alessandro Padovani; M. Di Luca


Archive | 2017

Platelet Amyloid Precursor Protein Abnormalities in Mild Cognitive Impairment Predict Conversion to Dementia of Alzheimer Type

B. Borroni; Francesca Colciaghi; Carlo Caltagirone; Luca Rozzini; Laura Broglio; Flaminio Cattabeni; Alessandro Padovani


World Journal of Meta-Analysis | 2014

Stroke and depression: A bidirectional link

Elisabetta Del Zotto; Paolo Costa; Andrea Morotti; Loris Poli; Valeria De Giuli; Alessia Giossi; Irene Volonghi; Antonio Callea; Alessandro Padovani; Alessandro Pezzini


Archive | 2018

A functional serotonin transporter gene polymorphism is associated with migraine with aura

B. Borroni; Cristina Brambilla, Renata Rao, Paolo Liberini, Silvana Archetti; Alessandro Padovani


Archive | 2018

Homocysteine, vitamin B6, and vascular disease in AD patients

B. Borroni; Chiara Agosti, Anna Franca Panzali, Monica Di Luca; Alessandro Padovani


Archive | 2018

Activities of daily living assessment in Frontotemporal Dementia

B. Borroni; Alessandro Padovani

Collaboration


Dive into the Alessandro Padovani's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge